Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,696 | 592 | 98.7% |
| Education | $111.73 | 12 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,186 | 55 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,079 | 73 | $0 (2023) |
| Lilly USA, LLC | $785.56 | 64 | $0 (2023) |
| Novo Nordisk Inc | $742.30 | 67 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $690.92 | 42 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $603.18 | 42 | $0 (2023) |
| PFIZER INC. | $512.48 | 38 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $364.25 | 23 | $0 (2022) |
| Merck Sharp & Dohme LLC | $323.83 | 25 | $0 (2022) |
| Amgen Inc. | $293.21 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $880.93 | 35 | AstraZeneca Pharmaceuticals LP ($291.97) |
| 2022 | $303.94 | 11 | Merck Sharp & Dohme LLC ($91.51) |
| 2021 | $11.61 | 1 | Novo Nordisk Inc ($11.61) |
| 2020 | $22.02 | 1 | Lilly USA, LLC ($22.02) |
| 2019 | $1,567 | 104 | GlaxoSmithKline, LLC. ($299.93) |
| 2018 | $2,948 | 199 | GlaxoSmithKline, LLC. ($395.50) |
| 2017 | $3,074 | 253 | Lilly USA, LLC ($362.39) |
All Payment Transactions
604 individual payment records from CMS Open Payments — Page 2 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $5.55 | General |
| Category: Respiratory | ||||||
| 03/23/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $39.61 | General |
| Category: Endocrinology | ||||||
| 03/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| 02/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA, FARXIGA | Food and Beverage | In-kind items and services | $95.98 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Urology | ||||||
| 01/25/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 01/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: INSOMNIA | ||||||
| 12/21/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: PRIMARY CARE | ||||||
| 12/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Respiratory | ||||||
| 11/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: PRIMARY CARE | ||||||
| 11/01/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $91.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/26/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Respiratory | ||||||
| 09/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.31 | General |
| Category: Cardiovascular | ||||||
| 04/30/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Diabetes | ||||||
| 11/09/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Diabetes | ||||||
| 09/17/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,051 | 1,973 | $372,512 | $142,015 |
| 2022 | 22 | 1,373 | 2,383 | $454,228 | $185,473 |
| 2021 | 21 | 952 | 1,978 | $390,178 | $153,672 |
| 2020 | 21 | 1,291 | 2,295 | $437,799 | $167,697 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 357 | 877 | $201,710 | $73,655 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 261 | $42,282 | $16,639 | 39.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 62 | $27,218 | $8,981 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $13,805 | $7,348 | 53.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 28 | $13,916 | $6,196 | 44.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 45 | 62 | $14,384 | $5,843 | 40.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 83 | 83 | $9,877 | $5,823 | 59.0% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 12 | 12 | $3,816 | $3,034 | 79.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 91 | 91 | $5,096 | $2,941 | 57.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $5,600 | $2,550 | 45.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 116 | 214 | $12,626 | $2,037 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 35 | $5,495 | $1,911 | 34.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 14 | $3,150 | $1,392 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,628 | $1,143 | 24.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $1,120 | $646.40 | 57.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 16 | $1,856 | $646.32 | 34.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 34 | $2,176 | $338.54 | 15.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 11 | 11 | $495.00 | $334.90 | 67.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 11 | $803.00 | $279.25 | 34.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 25 | $1,700 | $242.36 | 14.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 33 | $759.00 | $34.85 | 4.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 298 | 746 | $171,580 | $64,133 | 37.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 466 | $75,492 | $27,429 | 36.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 202 | 202 | $50,702 | $27,254 | 53.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 94 | $41,266 | $14,775 | 35.8% |
About Dr. Vanja Cuk, MD
Dr. Vanja Cuk, MD is a Internal Medicine healthcare provider based in Bloomingdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215022074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vanja Cuk, MD has received a total of $8,808 in payments from pharmaceutical and medical device companies, with $880.93 received in 2023. These payments were reported across 604 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,696).
As a Medicare-enrolled provider, Cuk has provided services to 4,667 Medicare beneficiaries, totaling 8,629 services with total Medicare billing of $648,858. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bloomingdale, IL
- Active Since 10/04/2006
- Last Updated 03/15/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215022074
Products in Payments
- ENTRESTO (Drug) $662.47
- FARXIGA (Drug) $538.23
- TRELEGY ELLIPTA (Drug) $487.61
- XARELTO (Drug) $471.65
- TRULICITY (Drug) $367.77
- Amitiza (Drug) $317.66
- CHANTIX (Drug) $312.87
- ANORO (Drug) $291.55
- BREO (Drug) $238.43
- HUMALOG (Drug) $230.48
- Victoza (Drug) $217.43
- BREZTRI (Drug) $187.29
- Prolia (Biological) $179.11
- Vascepa (Drug) $160.58
- TRADJENTA (Drug) $149.36
- SYMBICORT (Drug) $141.64
- Saxenda (Drug) $137.84
- JARDIANCE (Drug) $116.63
- Trintellix (Drug) $110.59
- JANUVIA (Drug) $105.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomingdale
Dr. Aziz Ahmed, M.d, M.D
Internal Medicine — Payments: $12,894
Dr. Sanjay Patel, M.d, M.D
Internal Medicine — Payments: $5,443
Dr. Mahrukh Subhani, M.d, M.D
Internal Medicine — Payments: $2,723
Robert Hurst, Md, MD
Internal Medicine — Payments: $1,136
Sonal Patel, Do, DO
Internal Medicine — Payments: $753.69
Wahaj Ahmed, M.d, M.D
Internal Medicine — Payments: $670.83